WINDTREE THERAPEUTICS INC /DE/ Earnings Per Share, Basic and Diluted
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Earnings Per Share, Basic and Diluted of -$2.73 per share for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-31.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-03-31
- WINDTREE THERAPEUTICS INC /DE/ earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.31.
- WINDTREE THERAPEUTICS INC /DE/ earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$1.42.
- WINDTREE THERAPEUTICS INC /DE/ earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.51.
- WINDTREE THERAPEUTICS INC /DE/ earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.54.
- WINDTREE THERAPEUTICS INC /DE/ earnings per share, basic and diluted for fiscal 2021 was -$2.73.
- WINDTREE THERAPEUTICS INC /DE/ earnings per share, basic and diluted for fiscal 2020 was -$2.08.
- WINDTREE THERAPEUTICS INC /DE/ earnings per share, basic and diluted for fiscal 2019 was -$2.51.
- WINDTREE THERAPEUTICS INC /DE/ earnings per share, basic and diluted for fiscal 2018 was -$7.74.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | -$2.73 10-K · filed 2022-03-31 | |||||||
| 2021-09-30 | -$0.31 10-Q · filed 2021-11-10 | -$2.31 10-Q · filed 2021-11-10 | ||||||
| 2021-06-30 | -$1.42 10-Q · filed 2021-08-05 | -$2.10 10-Q · filed 2021-08-05 | ||||||
| 2021-03-31 | -$0.51 10-Q · filed 2021-05-13 | |||||||
| 2020-12-31 | -$2.08 10-K · filed 2022-03-31 | |||||||
| 2020-09-30 | -$0.54 10-Q · filed 2021-11-10 | -$1.65 10-Q · filed 2021-11-10 | ||||||
| 2020-06-30 | -$0.63 10-Q · filed 2021-08-05 | -$1.12 10-Q · filed 2021-08-05 | ||||||
| 2020-03-31 | -$0.48 10-Q · filed 2021-05-13 | |||||||
| 2019-12-31 | -$0.21 10-K · filed 2020-04-03 | -$2.51 10-K · filed 2021-03-29 | -$0.84 10-K · filed 2020-04-03 | |||||
| 2019-09-30 | -$0.66 10-Q · filed 2020-11-16 | -$0.22 10-Q · filed 2019-11-14 | -$1.87 10-Q · filed 2020-11-16 | -$0.62 10-Q · filed 2019-11-14 | ||||
| 2019-06-30 | -$0.60 10-Q · filed 2020-08-14 | -$0.20 10-Q · filed 2019-08-14 | -$1.21 10-Q · filed 2020-08-14 | -$0.40 10-Q · filed 2019-08-14 | ||||
| 2019-03-31 | -$0.61 10-Q · filed 2020-05-13 | -$0.20 10-Q · filed 2019-05-20 | ||||||
| 2018-12-31 | -$3.24 10-K · filed 2020-04-03 | -$4.96 derived: net income ÷ weighted average shares · filed 2020-04-03 | -$6.17 derived: net income ÷ weighted average shares · filed 2020-04-03 | -$7.74 10-K · filed 2020-04-03 | ||||
| 2018-09-30 | -$1.04 10-K · filed 2020-04-03 | -$1.86 derived: net income ÷ weighted average shares · filed 2020-04-03 | -$3.21 10-Q · filed 2019-11-14 | -$3.98 derived: net income ÷ weighted average shares · filed 2020-04-03 | ||||
| 2018-06-30 | -$0.81 10-K · filed 2020-04-03 | -$2.17 10-Q · filed 2019-08-14 | -$2.89 derived: net income ÷ weighted average shares · filed 2020-04-03 | -$8.48 derived: net income ÷ weighted average shares · filed 2020-04-03 | ||||
| 2018-03-31 | -$1.40 10-K · filed 2020-04-03 | -$2.64 derived: net income ÷ weighted average shares · filed 2020-04-03 | -$12.83 derived: net income ÷ weighted average shares · filed 2020-04-03 | -$24.48 derived: net income ÷ weighted average shares · filed 2020-04-03 | ||||
| 2017-12-31 | -$1.47 derived: net income ÷ weighted average shares · filed 2019-04-23 | $10.89 derived: net income ÷ weighted average shares · filed 2019-04-23 | $83.46 derived: net income ÷ weighted average shares · filed 2019-04-23 | -$24.14 10-K/A · filed 2019-04-23 | ||||
| 2017-09-30 | -$10.53 10-Q · filed 2018-11-14 | -$0.69 10-Q · filed 2017-11-14 | -$24.21 derived: net income ÷ weighted average shares · filed 2019-04-23 | -$48.45 10-Q · filed 2018-11-14 | -$2.76 10-Q · filed 2017-11-14 | -$64.19 derived: net income ÷ weighted average shares · filed 2019-04-23 | ||
| 2017-06-30 | -$14.37 10-Q · filed 2018-08-14 | -$0.76 10-Q · filed 2017-08-21 | -$40.96 10-Q · filed 2018-08-14 | -$2.10 10-Q · filed 2017-08-21 | -$56.86 derived: net income ÷ weighted average shares · filed 2019-04-23 | -$76.80 derived: net income ÷ weighted average shares · filed 2019-04-23 | ||
| 2017-03-31 | -$27.40 10-Q · filed 2018-05-21 | -$1.37 10-Q · filed 2017-05-15 | -$43.22 derived: net income ÷ weighted average shares · filed 2019-04-23 | -$63.28 derived: net income ÷ weighted average shares · filed 2019-04-23 | -$88.90 derived: net income ÷ weighted average shares · filed 2019-04-23 | |||
| 2016-12-31 | -$15.40 10-K · filed 2018-04-17 | -$35.46 derived: net income ÷ weighted average shares · filed 2018-04-17 | -$61.12 derived: net income ÷ weighted average shares · filed 2018-04-17 | -$94.84 10-K · filed 2018-04-17 | -$4.74 10-K · filed 2017-03-31 | |||
| 2016-09-30 | -$20.00 10-K · filed 2018-04-17 | -$1.00 10-Q · filed 2016-11-14 | -$45.75 derived: net income ÷ weighted average shares · filed 2018-04-17 | -$3.98 10-Q · filed 2017-11-14 | ||||
| 2016-06-30 | -$25.80 10-K · filed 2018-04-17 | -$1.29 10-Q · filed 2016-08-10 | -$2.99 10-Q · filed 2017-08-21 | |||||
| 2016-03-31 | -$34.00 10-K · filed 2018-04-17 | -$1.70 10-Q · filed 2016-05-12 | ||||||
| 2015-12-31 | -$7.98 10-K · filed 2017-03-31 | |||||||
| 2015-09-30 | -$2.80 10-Q · filed 2016-11-14 | -$6.86 10-Q · filed 2016-11-14 | ||||||
| 2015-06-30 | -$1.82 10-Q · filed 2016-08-10 | -$3.78 10-Q · filed 2016-08-10 | ||||||
| 2015-03-31 | -$1.96 10-Q · filed 2016-05-12 | -$0.14 10-Q · filed 2015-05-11 | ||||||
| 2014-03-31 | -$0.14 10-Q · filed 2015-05-11 | |||||||
| 2013-12-31 | -$0.82 10-K · filed 2014-03-17 | |||||||
| 2013-03-31 | -$0.29 10-Q · filed 2014-05-12 | |||||||
| 2012-12-31 | -$0.16 10-K · filed 2014-03-17 | -$0.95 10-K · filed 2014-03-17 | ||||||
| 2012-09-30 | -$0.31 10-K · filed 2014-03-17 | -$0.80 10-Q · filed 2012-11-14 | ||||||
| 2012-06-30 | -$0.16 10-K · filed 2014-03-17 | -$0.49 10-Q · filed 2012-08-14 | ||||||
| 2012-03-31 | -$0.37 10-K · filed 2014-03-17 | |||||||
| 2011-12-31 | -$0.18 10-K · filed 2013-03-15 | -$0.93 10-K · filed 2014-03-17 | ||||||
| 2011-09-30 | -$0.20 10-K · filed 2013-03-15 | -$0.75 10-Q · filed 2012-11-14 | ||||||
| 2011-06-30 | -$0.34 10-K · filed 2013-03-15 | -$0.56 10-Q · filed 2012-08-14 | ||||||
| 2011-03-31 | -$0.21 10-K · filed 2013-03-15 | |||||||
| 2010-12-31 | -$1.65 10-K · filed 2013-03-15 | |||||||
| 2010-09-30 | -$0.51 10-Q · filed 2011-11-14 | -$1.23 10-Q · filed 2011-11-14 | ||||||
| 2010-06-30 | -$0.07 10-Q · filed 2011-08-15 | -$0.69 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |